Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback